Panacea Biotec Ltd
NSE:PANACEABIO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Panacea Biotec Ltd
Panacea Biotec Ltd
Revenue
Panacea Biotec Ltd
Revenue Peer Comparison
524663
526139
HESTERBIO
BIOCON
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
Revenue
₹5.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Revenue
₹76.5m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-27%
|
|
|
Transgene Biotek Ltd
BSE:526139
|
Revenue
₹2.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Revenue
₹408.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
26%
|
CAGR 10-Years
37%
|
|
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
Revenue
₹3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Biocon Ltd
NSE:BIOCON
|
Revenue
₹147.6B
|
CAGR 3-Years
27%
|
CAGR 5-Years
22%
|
CAGR 10-Years
18%
|
See Also
What is Panacea Biotec Ltd's Revenue?
Revenue
5.6B
INR
Based on the financial report for Mar 31, 2024, Panacea Biotec Ltd's Revenue amounts to 5.6B INR.
What is Panacea Biotec Ltd's Revenue growth rate?
Revenue CAGR 5Y
4%
Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Panacea Biotec Ltd have been -4% over the past three years , 4% over the past five years .
You don't have any saved screeners yet
